HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization of direct antiglobulin test-negative autoimmune hemolytic anemia: a study of 154 cases.

Abstract
Direct antiglobulin test (DAT)-negative (DAT-)autoimmune hemolytic anemia (AIHA) is empirically thought to show the same clinical conditions as DAT-positive (DAT+)AIHA, with the exception of an adequate amount of red blood cell (RBC)-bound immunoglobulin (Ig)G. We investigated the clinical characteristics of DAT-AIHA in comparison with DAT+AIHA. Of the 582 patients referred to our laboratory with undiagnosed hemolytic anemia, AIHA was clinically diagnosed in 216 patients (DAT-AIHA, n = 154; DAT+AIHA, n = 62). The percentage of reticulocytes, mean corpuscular volume, RBC-IgG levels, white blood cell count, and total protein (TP) levels were significantly higher in patients with DAT+AIHA than patients with DAT-AIHA. The hemoglobin level was significantly lower in patients with DAT+AIHA. No significant differences between patients with DAT-AIHA and DAT+AIHA existed with respect to age, gender, idiopathic/secondary nature, complications such as Evans syndrome, effectiveness of steroid treatment, or survival rate at 1 year following diagnosis. Patients with DAT-AIHA required significantly lower doses of steroids for maintenance therapy. Based on multivariate analysis of idiopathic DAT-AIHA (n = 110), TP and Evans syndrome were associated with the effectiveness of steroids (adjusted odds ratio [aOR], 1.36/[0.1 g/dl]; 95% confidence interval [CI], 1.01-1.84) and survival at the 1-year follow-up (aOR, 0.1; 95% CI, 0.01-0.88). Our results indicate that patients with DAT-AIHA generally suffer milder anemia and hemolysis than patients with DAT+AIHA, respond equally well to steroids, and have comparable survival at 1-year.
AuthorsToyomi Kamesaki, Tomonori Toyotsuji, Eiji Kajii
JournalAmerican journal of hematology (Am J Hematol) Vol. 88 Issue 2 Pg. 93-6 (Feb 2013) ISSN: 1096-8652 [Electronic] United States
PMID23169533 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Wiley Periodicals, Inc.
Chemical References
  • Blood Proteins
  • Immunoglobulin G
  • Steroids
Topics
  • Adult
  • Aged
  • Anemia, Hemolytic, Autoimmune (blood, drug therapy, immunology, physiopathology)
  • Blood Proteins (analysis)
  • Case-Control Studies
  • Coombs Test
  • Erythrocyte Indices
  • Erythrocytes (metabolism)
  • Female
  • Follow-Up Studies
  • Hemolysis
  • Humans
  • Immunoglobulin G (analysis, metabolism)
  • Maintenance Chemotherapy
  • Male
  • Middle Aged
  • Reticulocyte Count
  • Severity of Illness Index
  • Steroids (administration & dosage, therapeutic use)
  • Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: